A Case Report: An 11-year-old boy with peripheral T-cell lymphoma presenting after a five-year indolent inguinal lymphadenopathy

Cancer of the blood and lymph system often strikes with sudden, aggressive force, but the immune system's T-cells can sometimes behave in ways that defy these expectations. T-cells are a vital part of the body's defense force, trained in the thymus gland to hunt down infections and abnormal cells. When these cells become cancerous, they form a group of diseases known as T-cell lymphomas. In adults, a specific type called peripheral T-cell lymphoma is known for growing quickly and spreading widely, usually appearing over a few weeks or months. Medical experts generally expect this disease to announce itself with rapid swelling, fever, and weight loss. However, the rules of cancer are not always written in stone, and rare cases exist where the disease moves at a glacial pace before suddenly changing its nature. Understanding these unusual patterns is crucial because it challenges doctors to rethink how they identify and treat cancer in children, a group where this specific disease is exceptionally rare and lacks a standard treatment plan.

In Ethiopia, an eleven-year-old boy presented a medical puzzle that would take five years to fully unfold. For half a decade, he carried a small, painless lump in his right groin. It was a solitary swelling that never caused him pain, never turned red, and never seemed to bother him. It was so unremarkable that when a doctor examined it three years into its existence, a sample taken from the tissue offered no clear answer, and the family was sent home with reassurance. The boy continued his life, attending school and growing normally, while the lump remained stable. Then, in a dramatic shift, the situation changed over just three months. The once-stable lump began to grow rapidly, and the boy developed new, widespread swelling in his neck and abdomen, along with small nodules in his lungs. He had been diagnosed with a rare and aggressive form of cancer known as peripheral T-cell lymphoma, not otherwise specified. This diagnosis is a label used when a specific type of T-cell cancer cannot be pinpointed to a more common category, and it is typically characterized by a fast, dangerous course.

The medical team at Addis Ababa University and St. Paul's Hospital Millennium Medical College faced a complex challenge. The boy's history of a five-year stable lump did not fit the textbook description of this aggressive cancer, which usually takes hold and spreads within weeks. To understand what was happening, doctors performed a detailed examination of the tissue from the groin mass. They used a specialized panel of sixteen different markers, which act like chemical flags to identify the type of cells present. The results showed that the cancer cells were T-cells, confirmed by the presence of specific proteins on their surface. Crucially, the cells showed a mutation in a protein called p53, which is a sign of genetic instability often linked to more dangerous behavior in cancer. Despite the presence of this aggressive marker, the boy's body had not yet suffered the typical severe damage seen in such advanced cases; his blood counts remained relatively stable, and he had no signs of the rapid cell breakdown that usually accompanies such widespread disease.

Staging scans revealed the full extent of the spread. The cancer had moved beyond the groin to involve lymph nodes on both sides of the neck and large, connected masses in the abdomen and pelvis. It had also settled into the lungs as multiple small nodules. According to the standard system for measuring cancer spread, this was classified as stage four, the most advanced stage. Yet, the boy's bone marrow and the fluid surrounding his brain were clear of the disease, and his liver enzymes, which often rise when the body is under stress from cancer, remained normal. This combination of widespread disease with a surprisingly calm internal environment was unusual. The doctors noted that the cancer cells were dividing at a moderate rate, far slower than the frantic pace usually seen in this type of lymphoma, which typically divides rapidly.

Treatment required a careful strategy because there is no single, established standard of care for this rare cancer in children. The team initially started a common chemotherapy regimen but quickly switched to a more intensive protocol designed for a related type of lymphoma called anaplastic large cell lymphoma. This treatment involved a series of powerful drugs given in alternating cycles, including high doses of methotrexate and other agents that target rapidly dividing cells, along with medication injected into the spinal fluid to protect the brain. The boy tolerated the treatment well, without the severe side effects that often accompany such intensive therapy. After completing the course, the response was significant. The large masses in his abdomen shrank considerably, and the nodules in his lungs disappeared. While a small, rubbery lump remained in his groin, likely a scar or residual tissue, the overall picture showed a major improvement, with the disease retreating from its widespread state.

This case stands out because it documents a rare journey for a childhood cancer. The boy lived with a stable lump for five years, a period that suggests the cancer may have existed in a dormant or slow-growing state before transforming into an aggressive form. The presence of the p53 mutation in a tumor that had been quiet for so long raises the possibility that this genetic change was the trigger that turned a slow-moving problem into a fast-moving crisis. While the doctors could not prove exactly when the cancer began or what caused the shift, the case highlights a critical lesson for medical practice. A lymph node that persists in a child, even if it has been checked once and found to be unclear, should not be dismissed as harmless simply because it has been there for a long time. The story of this boy serves as a reminder that cancer can sometimes wear a mask of calmness for years before revealing its true nature, and that careful, persistent observation is essential when dealing with unexplained swellings in children.